Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 9 studies | 24% ± 12% | |
capillary endothelial cell | 6 studies | 28% ± 13% | |
glomerular endothelial cell | 3 studies | 19% ± 1% |
Insufficient scRNA-seq data for expression of PCDH12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2287.96 | 653 / 653 | 98% | 17.67 | 590 / 605 |
breast | 100% | 1645.40 | 459 / 459 | 97% | 12.15 | 1086 / 1118 |
adrenal gland | 100% | 1372.31 | 258 / 258 | 93% | 14.53 | 214 / 230 |
lung | 100% | 3715.66 | 578 / 578 | 85% | 7.68 | 984 / 1155 |
kidney | 100% | 1661.24 | 89 / 89 | 81% | 28.49 | 731 / 901 |
brain | 84% | 420.73 | 2229 / 2642 | 96% | 11.26 | 674 / 705 |
stomach | 95% | 513.52 | 341 / 359 | 79% | 6.40 | 226 / 286 |
intestine | 99% | 666.13 | 959 / 966 | 74% | 5.24 | 389 / 527 |
bladder | 100% | 872.24 | 21 / 21 | 72% | 5.54 | 364 / 504 |
ovary | 99% | 540.21 | 178 / 180 | 60% | 3.41 | 258 / 430 |
uterus | 100% | 895.53 | 170 / 170 | 53% | 4.05 | 243 / 459 |
esophagus | 84% | 543.09 | 1213 / 1445 | 67% | 4.93 | 123 / 183 |
pancreas | 56% | 206.98 | 183 / 328 | 94% | 8.87 | 168 / 178 |
liver | 61% | 289.83 | 138 / 226 | 85% | 7.07 | 346 / 406 |
prostate | 98% | 693.71 | 241 / 245 | 46% | 2.39 | 231 / 502 |
skin | 64% | 291.50 | 1154 / 1809 | 79% | 6.55 | 373 / 472 |
spleen | 100% | 4697.82 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 1791.89 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 100% | 1323.45 | 857 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 90% | 599.05 | 1199 / 1335 | 0% | 0 | 0 / 0 |
muscle | 77% | 307.28 | 615 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 66% | 3.30 | 19 / 29 |
tonsil | 0% | 0 | 0 / 0 | 62% | 3.58 | 28 / 45 |
eye | 0% | 0 | 0 / 0 | 60% | 2.83 | 48 / 80 |
peripheral blood | 9% | 26.64 | 88 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008038 | Biological process | neuron recognition |
GO_0060711 | Biological process | labyrinthine layer development |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0007155 | Biological process | cell adhesion |
GO_0016339 | Biological process | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO_0005977 | Biological process | glycogen metabolic process |
GO_0005911 | Cellular component | cell-cell junction |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | PCDH12 |
Protein name | PCDH12 protein Protocadherin 12 Protocadherin-12 (Vascular cadherin-2) (Vascular endothelial cadherin-2) (VE-cad-2) (VE-cadherin-2) [Cleaved into: Protocadherin-12, secreted form] |
Synonyms | UNQ395/PRO731 |
Description | FUNCTION: Cellular adhesion molecule that may play an important role in cell-cell interactions at interendothelial junctions (By similarity). Acts as a regulator of cell migration, probably via increasing cell-cell adhesion . Promotes homotypic calcium-dependent aggregation and adhesion and clusters at intercellular junctions (By similarity). Unable to bind to catenins, weakly associates with the cytoskeleton (By similarity). . |
Accessions | ENST00000231484.4 Q8IUP8 E5RJD4 ENST00000510041.1 Q9NPG4 Q7Z738 |